株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

輸液ポンプソフトウェアの世界市場 - 予測 2024年:投薬エラー削減ソフトウェア (DERS) ・臨床ワークフローソフトウェア・相互運用性ソフトウェア

Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024

発行 MarketsandMarkets 商品コード 820530
出版日 ページ情報 英文 147 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.86円で換算しております。
Back to Top
輸液ポンプソフトウェアの世界市場 - 予測 2024年:投薬エラー削減ソフトウェア (DERS) ・臨床ワークフローソフトウェア・相互運用性ソフトウェア Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024
出版日: 2019年04月04日 ページ情報: 英文 147 Pages
概要

世界の輸液ポンプソフトウェア市場規模は、2019年の7億4,200万米ドルから2024年までに10億4,400万米ドルへと、7.1%のCAGR (年間複合成長率) で拡大する見通しです。輸液ポンプソフトウェア市場の成長は、高齢者人口の急増に伴う慢性疾患の発症率の増加、外科処置数の増加、外来・在宅医療用輸液ポンプの需要拡大、および技術進歩などの要因に起因しています。しかし、輸液ポンプの頻繁な製品リコールは、同市場をある程度抑制する可能性があります。

当レポートでは、世界の輸液ポンプソフトウェア市場について調査分析し、製品タイプ・症状・エンドユーザー・地域別の市場分析と予測、競合情勢の分析、主要企業のプロファイルなど体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 輸液ポンプソフトウェア:市場概要
  • 地域分析:欧州の輸液ポンプソフトウェア市場、タイプ別
  • 輸液ポンプソフトウェア市場シェア:症状別
  • 輸液ポンプソフトウェア市場シェア:タイプ別
  • 輸液ポンプソフトウェア市場シェア:エンドユーザー別
  • 輸液ポンプソフトウェア市場:地域概要

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 輸液ポンプソフトウェア市場:タイプ別

  • イントロダクション
  • 投薬エラー削減ソフトウェア (DERS)
  • 臨床ワークフローソフトウェア
  • 相互運用性ソフトウェア
  • その他

第7章 輸液ポンプソフトウェア市場:症状別

  • イントロダクション
  • 一般輸液
  • 疼痛 & 麻酔管理
  • インスリン輸液
  • 化学療法
  • 経腸輸液
  • その他の症状

第8章 輸液ポンプソフトウェア市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 外来診療
  • 在宅医療
  • 大学・研究機関

第9章 輸液ポンプソフトウェア市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第10章 競合情勢

  • 概要
  • 競合リーダーシップマッピング
  • 競合シナリオ

第11章 企業プロファイル

  • BECTON, DICKINSON AND COMPANY (BD)
  • B. BRAUN MELSUNGEN AG (B. BRAUN)
  • BAXTER INTERNATIONAL INC. (BAXTER)
  • FRESENIUS KABI
  • ICU MEDICAL, INC. (ICU MEDICAL)
  • MEDTRONIC PLC (MEDTRONIC)
  • MOOG INC. (MOOG)
  • SMITHS MEDICAL (A DIVISION OF SMITHS GROUP PLC)
  • テルモ
  • ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN- LA ROCHE LTD.)
  • YPSOMED AG (YPSOMED)
  • MICREL MEDICAL DEVICES

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 INDICATIVE LIST OF PRODUCT RECALLS FOR INFUSION PUMP SOFTWARE (2015-2017)
  • TABLE 2 INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 3 INFUSION PUMP SOFTWARE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4 INFUSION PUMP SOFTWARE MARKET FOR DERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5 INFUSION PUMP CLINICAL WORKFLOW SOFTWARE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6 INFUSION PUMP INTEROPERABILITY SOFTWARE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7 OTHER INFUSION PUMP SOFTWARE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8 INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 9 INFUSION PUMP SOFTWARE MARKET FOR GENERAL INFUSION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10 INFUSION PUMP SOFTWARE MARKET FOR PAIN & ANESTHESIA MANAGEMENT, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11 INFUSION PUMP SOFTWARE MARKET FOR INSULIN INFUSION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12 INFUSION PUMP SOFTWARE MARKET FOR CHEMOTHERAPY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13 INFUSION PUMP SOFTWARE MARKET FOR ENTERAL INFUSION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14 INFUSION PUMP SOFTWARE MARKET FOR OTHER INDICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15 INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 16 INFUSION PUMP SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17 INFUSION PUMP SOFTWARE MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18 INFUSION PUMP SOFTWARE MARKET FOR HOME CARE SETTINGS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19 INFUSION PUMP SOFTWARE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20 INFUSION PUMP SOFTWARE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21 NORTH AMERICA: INFUSION PUMP SOFTWARE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22 NORTH AMERICA: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 23 NORTH AMERICA: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 24 NORTH AMERICA: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 25 US: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 26 US: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 27 US: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 28 CANADA: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 29 CANADA: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 30 CANADA: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 31 EUROPE: INFUSION PUMP SOFTWARE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 32 EUROPE: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 33 EUROPE: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 34 EUROPE: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 35 GERMANY: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 36 GERMANY: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 37 GERMANY: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 38 FRANCE: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 39 FRANCE: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 40 FRANCE: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 41 UK: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 42 UK: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 43 UK: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 44 ROE: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 45 ROE: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 46 ROE: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 47 ASIA PACIFIC INFUSION PUMP SOFTWARE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 51 CHINA: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52 CHINA: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 53 CHINA: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 54 JAPAN: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55 JAPAN: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 56 JAPAN: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 57 INDIA: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58 INDIA: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 59 INDIA: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 60 ROAPAC: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61 ROAPAC: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 62 ROAPAC: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 63 ROW: INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 64 ROW: INFUSION PUMP SOFTWARE MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 65 ROW: INFUSION PUMP SOFTWARE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 66 PRODUCT LAUNCHES AND APPROVALS
  • TABLE 67 EXPANSIONS
  • TABLE 68 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
  • TABLE 69 ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1 RESEARCH METHODOLOGY STEPS
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 INFUSION PUMP SOFTWARE MARKET : BOTTOM-UP APPROACH
  • FIGURE 5 INFUSION PUMP SOFTWARE MARKET: TOP-DOWN APPROACH
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • FIGURE 7 INFUSION PUMP SOFTWARE MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8 INFUSION PUMP SOFTWARE MARKET SHARE, BY INDICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9 INFUSION PUMP SOFTWARE MARKET SHARE, BY END USER, 2018
  • FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE INFUSION PUMP SOFTWARE MARKET
  • FIGURE 11 INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 12 GERMANY TO ACCOUNT FOR THE LARGEST SHARE IN THE EUROPEAN INFUSION PUMP SOFTWARE MARKET IN 2019
  • FIGURE 13 GENERAL INFUSION SEGMENT TO DOMINATE THE INFUSION PUMP SOFTWARE MARKET DURING THE FORECAST PERIOD
  • FIGURE 14 DERS SEGMENT TO ACCOUNT FOR THE DOMINANT SHARE OF THE MARKET IN 2019
  • FIGURE 15 HOSPITALS TO DOMINATE THE INFUSION PUMP SOFTWARE MARKET IN 2024
  • FIGURE 16 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17 INFUSION PUMP SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 GLOBAL CANCER INCIDENCE, 2008-2030
  • FIGURE 19 ESTIMATED DIABETIC POPULATION, BY REGION, 2015 VS. 2040
  • FIGURE 20 DERS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE INFUSION PUMP SOFTWARE MARKET DURING THE FORECAST PERIOD
  • FIGURE 21 INSULIN INFUSION SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 22 HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE IN THE INFUSION PUMP SOFTWARE MARKET IN 2018
  • FIGURE 23 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE INFUSION PUMP SOFTWARE MARKET IN 2018
  • FIGURE 24 NORTH AMERICA: INFUSION PUMP SOFTWARE MARKET SNAPSHOT
  • FIGURE 25 EUROPE: INFUSION PUMP SOFTWARE MARKET SNAPSHOT
  • FIGURE 26 APAC: INFUSION PUMP SOFTWARE MARKET SNAPSHOT
  • FIGURE 27 ROW: INFUSION PUMP SOFTWARE MARKET SNAPSHOT
  • FIGURE 28 KEY DEVELOPMENTS IN THE INFUSION PUMP SOFTWARE MARKET BETWEEN 2016 AND 2018
  • FIGURE 29 INFUSION PUMP SOFTWARE MARKET RANKING, BY KEY PLAYER
  • FIGURE 30 INFUSION PUMP SOFTWARE MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 32 B. BRAUN: COMPANY SNAPSHOT (2017)
  • FIGURE 33 BAXTER: COMPANY SNAPSHOT (2017)
  • FIGURE 34 FRESENIUS KABI: COMPANY SNAPSHOT (2017)
  • FIGURE 35 ICU MEDICAL: COMPANY SNAPSHOT (2017)
  • FIGURE 36 MEDTRONIC: COMPANY SNAPSHOT (2017)
  • FIGURE 37 MOOG: COMPANY SNAPSHOT (2018)
  • FIGURE 38 SMITHS MEDICAL: COMPANY SNAPSHOT (2018)
  • FIGURE 39 TERUMO CORPORATION: GENERAL HOSPITAL COMPANY SEGMENT SNAPSHOT (2017)
  • FIGURE 40 ROCHE: COMPANY SNAPSHOT (2018)
  • FIGURE 41 YPSOMED: COMPANY SNAPSHOT (2017)
目次
Product Code: HIT 7013

"The infusion pump software market is projected to grow at a CAGR of 7.1% during the forecast period."

The global infusion pump software market is projected to reach 1,044 million by 2024 from USD 742 million in 2019 at a CAGR of 7.1%. Growth in the infusion pump software market can be attributed to factors such as increasing incidence of chronic diseases, along with rapid growth in the geriatric population, growing number of surgical procedures performed, rising demand for ambulatory and home care infusion pumps, and technological developments. However, frequent product recalls of infusion pumps may restrain the market to a certain extent.

"The DERS segment is expected to hold the largest market share during the forecast period."

On the basis of type, the global infusion pump software market has been segmented into Dose error reduction software (DERS), clinical workflow software, interoperability software and other software. The DERS segment is expected to hold the largest market share during the forecast period. DERS is offered as a part of the drug library incorporated in the infusion pump. This software aids in preventing incorrect dosage of medicine by alerting the clinician via alarm. Subsequently, increasing number of reported medication errors using infusion pumps is a major factor boosting this market growth.

"The insulin infusion segment is expected to grow at the highest rate during the forecast period."

On the basis of indication, the infusion pump software market is segmented into general infusion, pain & anesthesia management, insulin infusion, chemotherapy, enteral infusion, and others. The general infusion segment is expected to take the largest share of this market. The high growth of this segment can be attributed to factors such as the ease and safety offered by infusion pumps software for delivery of medication.

"The Home care settings segment is expected to grow at the highest rate during the forecast period."

On the basis of end user, the infusion pump software market is segmented into hospitals, ambulatory care settings, home care settings, and academic & research institutes. The home care settings segment is expected to grow at the highest rate during the forecast period. The high growth of this segment can be attributed to factors such as increasing preference for treatment at one's convenience and the advantage of home infusion being highly cost effective.

"The Asia Pacific infusion pump software market is expected to grow at the highest rate during the forecast period."

Geographically, the infusion pump software market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest rate during the forecast period. The high growth in this region can be attributed to the a large population pool, increasing aging population, growing incidences of chronic diseases, increased awareness and accessibility of advanced healthcare facilities, and rising healthcare spending.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 55%, Tier 2 - 20%, and Tier 3 - 25%
  • By Designation: C-level - 35%, Director-level - 25%, and Others - 40%
  • By Region: North America - 20%, Europe - 25%, APAC - 40%, and RoW - 15%

The major players in the market include BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), Terumo Medical (Japan), Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).

Research Coverage

This report studies the infusion pump software market based on type, end user, indication, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the infusion pump software market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • 2.1.3 PRIMARY SOURCES
      • 2.1.3.1 key insights from primary sources
      • 2.1.3.2 Market size estimation methodology
    • 2.1.4 MARKET DATA ESTIMATION AND TRIANGULATION
  • 2.2 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 INFUSION PUMP SOFTWARE MARKET OVERVIEW
  • 4.2 GEOGRAPHIC ANALYSIS: EUROPEAN INFUSION PUMP SOFTWARE MARKET SHARE, BY TYPE, 2019
  • 4.3 INFUSION PUMP SOFTWARE MARKET SHARE, BY INDICATION, 2019 VS. 2024
  • 4.4 INFUSION PUMP SOFTWARE MARKET SHARE, BY TYPE, 2019 VS. 2024
  • 4.5 INFUSION PUMP SOFTWARE MARKET SHARE, BY END USER, 2019 VS. 2024
  • 4.6 INFUSION PUMP SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing incidence of chronic diseases and rapid growth in geriatric population
      • 5.2.1.2 Growing number of surgical procedures performed
      • 5.2.1.3 Rising demand for ambulatory and home care infusion pumps
      • 5.2.1.4 Technological developments
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Frequent product recalls of infusion pumps
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Untapped emerging markets
      • 5.2.3.2 Growing adoption of specialty infusion systems
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing incidence of medication errors and lack of wireless connectivity in most hospitals

6 INFUSION PUMP SOFTWARE MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 DOSE ERROR REDUCTION SOFTWARE (DERS)
    • 6.2.1 INCREASING INCIDENCE OF MEDICATION ERRORS IS DRIVING THE DEMAND FOR DERS IN INFUSION PUMPS
  • 6.3 CLINICAL WORKFLOW SOFTWARE
    • 6.3.1 CLINICAL WORKFLOW SOFTWARE ENABLES AUTOMATION OF THE ENTIRE PROCESS OF A PATIENT'S ASSESSMENT AND TREATMENT
  • 6.4 INTEROPERABILITY SOFTWARE
    • 6.4.1 INTEROPERABILITY SOFTWARE HELPS IN REDUCING MANUAL PROGRAMMING ERRORS
  • 6.5 OTHERS

7 INFUSION PUMP SOFTWARE MARKET, BY INDICATION

  • 7.1 INTRODUCTION
  • 7.2 GENERAL INFUSION
    • 7.2.1 AVAILABILITY OF SAFER AND EFFICIENT INFUSION PUMPS TO PROPEL THE MARKET FOR GENERAL INFUSION
  • 7.3 PAIN & ANESTHESIA MANAGEMENT
    • 7.3.1 HIGH INCIDENCE OF CHRONIC PAIN WILL DRIVE THE MARKET FOR PAIN MANAGEMENT
  • 7.4 INSULIN INFUSION
    • 7.4.1 SIGNIFICANT INCREASE IN THE GLOBAL PREVALENCE OF DIABETES WILL DRIVE MARKET GROWTH
  • 7.5 CHEMOTHERAPY
    • 7.5.1 DEMAND FOR CONTROLLED AND TARGETED DELIVERY OF MEDICATION TO DRIVE THE CHEMOTHERAPY MARKET
  • 7.6 ENTERAL INFUSION
    • 7.6.1 INFUSION PUMPS FACILITATE CONTINUOUS AND CONTROLLED PARENTERAL FLOW
  • 7.7 OTHER INDICATIONS

8 INFUSION PUMP SOFTWARE MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 HOSPITALS DOMINATE THE INFUSION PUMP SOFTWARE MARKET, BY END USER
  • 8.3 AMBULATORY CARE SETTINGS
    • 8.3.1 NEED TO REDUCE HEALTHCARE EXPENDITURE HAS BOOSTED THE PREFERENCE FOR AMBULATORY CARE
  • 8.4 HOME CARE SETTINGS
    • 8.4.1 RISING ACCEPTANCE AND COST-EFFICIENCY OF HOME CARE PRODUCTS HAVE DRIVEN THEIR USE
  • 8.5 ACADEMIC & RESEARCH INSTITUTES
    • 8.5.1 RISING DRUG DISCOVERY ACTIVITY AND INCIDENCE OF MEDICATION ERRORS IS DRIVING MARKET GROWTH

9 INFUSION PUMP SOFTWARE MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 US is the largest market for infusion pump software
    • 9.2.2 CANADA
      • 9.2.2.1 Favorable reimbursement scenario for infusion pumps to propel the market in Canada
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the fastest-growing market for infusion pump software in Europe
    • 9.3.2 FRANCE
      • 9.3.2.1 The healthcare system in France is among the best in the world
    • 9.3.3 UK
      • 9.3.3.1 High number of medication errors in the UK to drive market growth
    • 9.3.4 ROE
  • 9.4 APAC
    • 9.4.1 CHINA
      • 9.4.1.1 Growing investments in healthcare infrastructure to support market growth
    • 9.4.2 JAPAN
      • 9.4.2.1 Rapid growth in the geriatric population and the rising prevalence of age-related illnesses to drive market growth
    • 9.4.3 INDIA
      • 9.4.3.1 High prevalence of lifestyle diseases to drive the market for infusion pump software
    • 9.4.4 ROAPAC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • 10.1.1 MARKET RANKING OF PLAYERS, 2018
  • 10.2 COMPETITIVE LEADERSHIP MAPPING
    • 10.2.1 VISIONARY LEADERS
    • 10.2.2 INNOVATORS
    • 10.2.3 DYNAMIC DIFFERENTIATORS
    • 10.2.4 EMERGING COMPANIES
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 PRODUCT LAUNCHES
    • 10.3.2 EXPANSIONS
    • 10.3.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 10.3.4 ACQUISITIONS

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 BECTON, DICKINSON AND COMPANY (BD)
  • 11.2 B. BRAUN MELSUNGEN AG (B. BRAUN)
  • 11.3 BAXTER INTERNATIONAL INC. (BAXTER)
  • 11.4 FRESENIUS KABI
  • 11.5 ICU MEDICAL, INC. (ICU MEDICAL)
  • 11.6 MEDTRONIC PLC (MEDTRONIC)
  • 11.7 MOOG INC. (MOOG)
  • 11.8 SMITHS MEDICAL (A DIVISION OF SMITHS GROUP PLC)
  • 11.9 TERUMO CORPORATION
  • 11.10 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN- LA ROCHE LTD.)
  • 11.11 YPSOMED AG (YPSOMED)
  • 11.12 MICREL MEDICAL DEVICES

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Back to Top